JP Morgan Chase
OTIC

JP Morgan Chase’s Otonomy, Inc. OTIC Stock Holding History

JP Morgan Chase’s Portfolio OTIC Stock Details OTIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-18
Closed – – 5908
2020
Q2 		$0 Sell
18
-31,088
-100% -$80.9K ﹤0.01% 5821
2020
Q1 		$61K Buy
31,106
+18,995
+157% +$58.5K ﹤0.01% 4680
2019
Q4 		$46K Buy
+12,111
New +$29.6K ﹤0.01% 5156
2019
Q3 		– Sell
-111,097
Closed -$281K – 6046
2019
Q2 		$281K Sell
111,097
-80,870
-42% -$215K ﹤0.01% 4513
2019
Q1 		$505K Buy
191,967
+32,770
+21% +$73.8K ﹤0.01% 4205
2018
Q4 		$295K Sell
159,197
-29,836
-16% -$70.4K ﹤0.01% 4405
2018
Q3 		$520K Sell
189,033
-59,462
-24% -$191K ﹤0.01% 4260
2018
Q2 		$957K Sell
248,495
-17,276
-7% -$71.9K ﹤0.01% 3856
2018
Q1 		$1.12M Buy
265,771
+259,672
+4,258% +$1.41M ﹤0.01% 3618
2017
Q4 		$34K Buy
+6,099
New +$26.5K ﹤0.01% 5023
2017
Q3 		– Sell
-517,410
Closed -$9.75M – 5266
2017
Q2 		$9.75M Buy
517,410
+512,320
+10,065% +$7.14M ﹤0.01% 1991
2017
Q1 		$62K Sell
5,090
-605
-11% -$8.81K ﹤0.01% 4471
2016
Q4 		$91K Buy
5,695
+749
+15% +$12.5K ﹤0.01% 4424
2016
Q3 		$90K Sell
4,946
-64
-1% -$1.05K ﹤0.01% 3890
2016
Q2 		$80K Hold
5,010
– – ﹤0.01% 3919
2016
Q1 		$75K Sell
5,010
-8,905
-64% -$140K ﹤0.01% 3807
2015
Q4 		$386K Buy
+13,915
New +$346K ﹤0.01% 3479
2015
Q3 		– Sell
-25,677
Closed -$590K – 4139
2015
Q2 		$590K Buy
+25,677
New +$720K ﹤0.01% 3503
2015
Q1 		– Sell
-88,314
Closed -$2.94M – 4330
2014
Q4 		$2.94M Buy
88,314
+63,314
+253% +$1.7M ﹤0.01% 2734
2014
Q3 		$600K Buy
+25,000
New +$494K ﹤0.01% 3581

Other funds holding OTIC

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
First Manhattan
First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PVI
Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

JP Morgan Chase's OTIC Position: Q3 2020 in Review

JP Morgan Chase sold out of Otonomy, Inc. (OTIC) in Q3 2020, closing a stake of 18 shares.

JP Morgan Chase first reported a position in OTIC in Q3 2014 and held it in 20 quarters. The position peaked at $9.75M in Q2 2017. 68 funds tracked by Wall St. Rank hold OTIC as of Q3 2020.

  • JP Morgan Chase reported no remaining Otonomy, Inc. position as of Q3 2020 after selling out during the quarter.
  • JP Morgan Chase sold 18 Otonomy, Inc. shares in Q3 2020.
  • JP Morgan Chase first reported a position in Otonomy, Inc. in Q3 2014 and held it in 20 quarters.
  • JP Morgan Chase's Otonomy, Inc. position peaked at $9.75M in Q2 2017.
  • 68 funds tracked by Wall St. Rank held Otonomy, Inc. as of Q3 2020.

Based on JP Morgan Chase's 13F filing for Q3 2020, filed 12 Nov 2020.